KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 103 filers reported holding KEROS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,645 | -27.9% | 2,561 | -9.1% | 0.05% | -25.4% |
| Q2 2023 | $113,227 | +31.5% | 2,818 | +39.7% | 0.07% | +42.6% |
| Q1 2023 | $86,126 | -35.7% | 2,017 | -27.7% | 0.05% | -32.9% |
| Q4 2022 | $133,880 | -7.0% | 2,788 | -27.1% | 0.07% | +22.8% |
| Q3 2022 | $144,000 | +37.1% | 3,825 | +0.8% | 0.06% | +46.2% |
| Q2 2022 | $105,000 | -40.0% | 3,793 | +17.6% | 0.04% | -50.0% |
| Q1 2022 | $175,000 | -12.5% | 3,225 | -5.6% | 0.08% | +2.6% |
| Q4 2021 | $200,000 | +25.8% | 3,416 | -14.9% | 0.08% | +8.6% |
| Q3 2021 | $159,000 | -11.7% | 4,016 | -5.0% | 0.07% | -5.4% |
| Q2 2021 | $180,000 | -23.7% | 4,229 | +10.3% | 0.07% | -26.0% |
| Q1 2021 | $236,000 | -10.9% | 3,835 | +2.0% | 0.10% | -9.1% |
| Q4 2020 | $265,000 | – | 3,758 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |